Your email has been successfully added to our mailing list.

×
0.00265184998105806 0.00265184998105806 0.00265184998105806 0.00265184998105806 0.00265184998105806 0.0114913499179188 0.00265184998105806 0.00265184998105806
Stock impact report

Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Proteostasis Therapeutics, Inc (PTI)  More Company Research Source: PR Newswire
Last proteostasis therapeutics, inc earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
PDF BOSTON, Aug. 7, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced financial results for the second quarter ended June 30, 2019 and provided a corporate update. "PTI continues to advance the clinical development of our proprietary combination cystic fibrosis transmembrane conductance regulator (CFTR) modulators.  We recently initiated dosing in the 28-day global Phase 2 study of our doublet (PTI-808 and PTI-801) and triplet (PTI-808, PTI-801 and PTI-428) combinations in F508del homozygous and heterozygous CF subjects and we remain on track to report top line results from this study in the first quarter of 2020. The CF community continues to seek alternatives to today's standard of care CFTR modulator therapy, validating PTI's mission to provide addi [Read more]
Impact snapshot Event time: PTI
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
PTI alerts
from News Quantified
Opt-in for
PTI alerts

from News Quantified
Opt-in for
PTI alerts

from News Quantified